Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Posts
- Category: hdbuzz (continued)
- Huntington's disease therapeutics conference 2019 - Day 1
- Huntington's disease therapeutics conference 2019 - Day 2
- Huntington's disease therapeutics conference 2019 - Day 3
- Huntington’s disease therapeutics conference 2020 - Day 1
- Huntington’s disease therapeutics conference 2020 - Day 2
- Huntington’s disease therapeutics conference 2020 - Day 3
- Il trapianto di midollo osseo nella malattia di Huntington
- Illuminating findings in blood cells from Huntington's disease patients
- Illuminating the progression of Huntington’s disease
- Important advances in next generation genome editing tools for Huntington's Disease
- Important drug targets yielded by new genetic study of HD
- Interview: Alice and Nancy Wexler
- Interview: CHDI's scientific team
- Is access to predictive genetic testing for Huntington's disease a problem?
- Joint HDBuzz Prizewinner: Pennies for your neurons — copper’s bad influence on Huntington’s disease
- Joint HDBuzz Prizewinner: Yeast studies suggest a new way to protect cells from 'oxidative damage'
- Jumping genes: Huntington's disease protein invades brain transplants
- La strada si illumina: Un nuovo biomarcatore per la Malattia di Huntington
- Landmark study puts Huntington's disease trials on TRACK
- Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
- Liftoff: First humans treated with gene silencing drugs for HD!
- Lighting the way: A new biomarker for Huntington’s disease
- Lithium with a twist gets second chance for HD
- Looking Past the Spin: Results from a Clinical Trial of Cysteamine
- Mapping the anatomy of HD: a whole-brain history
- Mapping the neighborhood: huntingtin's new protein partners
- Measuring harmful huntingtin protein in the brain’s bath water
- Melatonin alterations in Huntington's disease help explain trouble with sleep
- More evidence points to Huntington's disease exercise benefit
- mTORC1 tips the scales in Huntington’s disease mice
- New collaboration seeks to speed Huntington's disease drug licensing
- New interest in an old target
- New molecule can reverse the Huntington's disease mutation in lab models
- New results bring BDNF therapies into focus
- New roles for huntingtin: removing a healthy protein to understand its function
- New study reveals a potential HD biomarker
- New tool to measure outcomes in Huntington’s Disease clinical trials
- Novel research technique suggests an antioxidant gene protects vulnerable neurons
- NUB1: enhancing clearance to decrease mutant huntingtin
- Nuova sperimentazione del PBT2 prodotto dalla Prana Biotech per la malattia di Huntington: notizie importanti
- Of mice and men: using animal models to study Huntington's disease
- Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
- Phosphodiesterase inhibitors: new HD drugs entering trials soon
- Planting trees together: The 2016 Huntington's Disease Society of America Convention
- Positive results announced for re-worked tetrabenazine drug in Huntington's disease
- Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
- Prana Biotech publishes Huntington's disease animal model data for PBT2
- Precision huntingtin-lowering drug trials target the mutant protein
- Prominent Huntington's disease researcher "fabricated data" in grant applications
- Proposed Huntington's disease 'biomarker' is not useful, new study suggests
Plugin by dagondesign.com
